325 related articles for article (PubMed ID: 25804575)
1. Extracting biomarkers of commitment to cancer development: potential role of vibrational spectroscopy in systems biology.
Theophilou G; Paraskevaidi M; Lima KM; Kyrgiou M; Martin-Hirsch PL; Martin FL
Expert Rev Mol Diagn; 2015 May; 15(5):693-713. PubMed ID: 25804575
[TBL] [Abstract][Full Text] [Related]
2. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
3. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
4. Integration of 'omics' data in aging research: from biomarkers to systems biology.
Zierer J; Menni C; Kastenmüller G; Spector TD
Aging Cell; 2015 Dec; 14(6):933-44. PubMed ID: 26331998
[TBL] [Abstract][Full Text] [Related]
5. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
Cisek K; Krochmal M; Klein J; Mischak H
Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
[TBL] [Abstract][Full Text] [Related]
6. From -omics to personalized medicine in nephrology: integration is the key.
Pesce F; Pathan S; Schena FP
Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
[TBL] [Abstract][Full Text] [Related]
7. An "Omics" based survey of human colon cancer.
Nambiar PR; Gupta RR; Misra V
Mutat Res; 2010 Nov; 693(1-2):3-18. PubMed ID: 20691711
[TBL] [Abstract][Full Text] [Related]
8. Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science.
Zhang C; Hong H; Mendrick DL; Tang Y; Cheng F
Biomark Med; 2015; 9(11):1241-52. PubMed ID: 26506997
[TBL] [Abstract][Full Text] [Related]
9. Integration of 'omics' data: does it lead to new insights into host-microbe interactions?
Kint G; Fierro C; Marchal K; Vanderleyden J; De Keersmaecker SC
Future Microbiol; 2010 Feb; 5(2):313-28. PubMed ID: 20143952
[TBL] [Abstract][Full Text] [Related]
10. [Research progress and trend analysis of biology and chemistry of Taxus medicinal resources].
Hao DC; Xiao PG; Peng Y; Liu M; Huo L
Yao Xue Xue Bao; 2012 Jul; 47(7):827-35. PubMed ID: 22993844
[TBL] [Abstract][Full Text] [Related]
11. Novel molecular events in oral carcinogenesis via integrative approaches.
Wu RQ; Zhao XF; Wang ZY; Zhou M; Chen QM
J Dent Res; 2011 May; 90(5):561-72. PubMed ID: 20940368
[TBL] [Abstract][Full Text] [Related]
12. Integrative system biology strategies for disease biomarker discovery.
Zhang H; Hu H; Deng C; Chun Y; Zhou S; Huang F; Zhou Q
Comb Chem High Throughput Screen; 2012 May; 15(4):286-98. PubMed ID: 22221061
[TBL] [Abstract][Full Text] [Related]
13. Multi-omic data integration and analysis using systems genomics approaches: methods and applications in animal production, health and welfare.
Suravajhala P; Kogelman LJ; Kadarmideen HN
Genet Sel Evol; 2016 Apr; 48(1):38. PubMed ID: 27130220
[TBL] [Abstract][Full Text] [Related]
14. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics.
Merrick BA; London RE; Bushel PR; Grissom SF; Paules RS
IARC Sci Publ; 2011; (163):121-42. PubMed ID: 22997859
[TBL] [Abstract][Full Text] [Related]
15. Data analysis methods for defining biomarkers from omics data.
Li C; Gao Z; Su B; Xu G; Lin X
Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
[TBL] [Abstract][Full Text] [Related]
16. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
[TBL] [Abstract][Full Text] [Related]
17. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.
Russell C; Rahman A; Mohammed AR
Ther Deliv; 2013 Mar; 4(3):395-413. PubMed ID: 23442083
[TBL] [Abstract][Full Text] [Related]
18. Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.
Guhathakurta D; Sheikh NA; Meagher TC; Letarte S; Trager JB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):387-401. PubMed ID: 23927667
[TBL] [Abstract][Full Text] [Related]
19. Evolving 'omics' technologies for diagnostics of head and neck cancer.
Nagaraj NS
Brief Funct Genomic Proteomic; 2009 Jan; 8(1):49-59. PubMed ID: 19273537
[TBL] [Abstract][Full Text] [Related]
20. Omics approaches to probe markers of disease resistance in animal sciences.
Guillemin N; Horvatić A; Kuleš J; Galan A; Mrljak V; Bhide M
Mol Biosyst; 2016 Jun; 12(7):2036-46. PubMed ID: 27197117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
